A response to the commentary “The role of mineralocorticoid receptor dysregulation in the neurocognitive impairment of patients recovered from depression” by Preston, S., Watson, S. and Gallagher, P. on” Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression” by Behnken, A. et al.